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Abstract The AntiPhospholipid Syndrome (APS) is an ac-
quired autoimmune disorder induced by high levels of
antiphospholipid antibodies that cause arterial and veins
thrombosis, as well as pregnancy-related complications and
morbidity, as clinical manifestations. This autoimmune hyper-
coagulable state, usually known as Hughes syndrome, has
severe consequences for the patients, being one of the main
causes of thrombotic disorders and death. Therefore, it is re-
quired to be preventive; being aware of how probable is to
have that kind of syndrome. Despite the updated of
antiphospholipid syndrome classification, the diagnosis re-
mains difficult to establish. Additional research on clinically
relevant antibodies and standardization of their quantification
are required in order to improve the antiphospholipid
syndrome risk assessment. Thus, this work will focus on the
development of a diagnosis decision support system in terms
of a formal agenda built on a Logic Programming approach to
knowledge representation and reasoning, complemented with
a computational framework based on Artificial Neural
Networks. The proposed model allows for improving the di-
agnosis, classifying properly the patients that really presented
this pathology (sensitivity higher than 85%), as well as clas-
sifying the absence of APS (specificity close to 95%).
Keywords Antiphospholipid syndrome . Systemic
autoimmune diseases . Artificial neuronal networks .
Knowledgerepresentationandreasoning .Logicprogramming
This article is part of the Topical Collection on Systems-Level Quality
Improvement.
* José Neves
jneves@di.uminho.pt
João Vilhena
jmvilhena@gmail.com
M. Rosário Martins
mrm@uevora.pt
Henrique Vicente
hvicente@uevora.pt
José M. Grañeda
graneda1@sapo.pt
Filomena Caldeira
filomenacaldeira1@gmail.com
Rodrigo Gusmão
gusmao.rodrigo@gmail.com
João Neves
joaocpneves@gmail.com
1 Departamento de Química, Escola de Ciências e Tecnologia,
Universidade de Évora, 7000-671 Évora, Portugal
2 Departamento de Química, Laboratório HERCULES, Escola de
Ciências e Tecnologia, Universidade de Évora,
7000-671 Évora, Portugal
3 Centro Algoritmi, Universidade do Minho,
4710-057 Braga, Portugal
4 Serviço de Patologia Clínica do Hospital do Espírito Santo de Évora
EPE, Évora, Portugal
5 Drs. Nicolas & Asp, Dubai, United Arab Emirates
J Med Syst  (2017) 41:40 
DOI 10.1007/s10916-017-0688-5
